These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2834447

  • 21. A monoclonal antibody (100C5) to the Lyt-2-T cell population expanding in MRL/Mp-lpr/lpr mice detects a surface antigen normally expressed on Lyt-2+ cells and B cells.
    Dumont FJ, Habbersett RC, Nichols EA, Treffinger JA, Tung AS.
    Eur J Immunol; 1983 Jun; 13(6):455-9. PubMed ID: 6602708
    [Abstract] [Full Text] [Related]

  • 22. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE, Wofsy D, Greenspan JS, Ledbetter JA.
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [Abstract] [Full Text] [Related]

  • 23. Xenogeneic monoclonal antibody to an Ly-6-linked murine cell surface antigen: differential reactivity with T cell subpopulations and bone marrow cells.
    Dumont FJ, Coker LZ, Habbersett RC, Treffinger JA.
    J Immunol; 1985 Apr; 134(4):2357-65. PubMed ID: 3156181
    [Abstract] [Full Text] [Related]

  • 24. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [Abstract] [Full Text] [Related]

  • 25. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 15; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 26. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T, Davidson WF.
    J Immunol; 1994 Feb 15; 152(4):2000-10. PubMed ID: 8120404
    [Abstract] [Full Text] [Related]

  • 27. Recirculation, phenotype and functions of lymphocytes in mice treated with monoclonal antibody MEL-14.
    Lepault F, Gagnerault MC, Faveeuw C, Boitard C.
    Eur J Immunol; 1994 Dec 15; 24(12):3106-12. PubMed ID: 7528669
    [Abstract] [Full Text] [Related]

  • 28. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required.
    Weston KM, Ju ST, Lu CY, Sy MS.
    J Immunol; 1988 Sep 15; 141(6):1941-8. PubMed ID: 3139746
    [Abstract] [Full Text] [Related]

  • 29. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes.
    Sobel ES, Yokoyama WM, Shevach EM, Eisenberg RA, Cohen PL.
    J Immunol; 1993 Jan 15; 150(2):673-82. PubMed ID: 8380429
    [Abstract] [Full Text] [Related]

  • 30. Suppression of antigen-specific interleukin 2 production in the MRL/MpJ-lpr/lpr mouse.
    Naides SJ.
    J Immunol; 1986 Jun 01; 136(11):4113-21. PubMed ID: 2422273
    [Abstract] [Full Text] [Related]

  • 31. T cell lineages in the thymus of lpr/lpr mice. Evidence for parallel pathways of normal and abnormal T cell development.
    Budd RC, Schreyer M, Miescher GC, MacDonald HR.
    J Immunol; 1987 Oct 01; 139(7):2200-10. PubMed ID: 3498754
    [Abstract] [Full Text] [Related]

  • 32. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
    Asensi V, Kimeno K, Kawamura I, Sakumoto M, Nomoto K.
    Immunology; 1989 Oct 01; 68(2):204-8. PubMed ID: 2478453
    [Abstract] [Full Text] [Related]

  • 33. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S, Yuan D, Katagiri T, Eisenberg RA, Cohen PL, Ting JP.
    J Immunol; 1987 Oct 15; 139(8):2810-7. PubMed ID: 3116095
    [Abstract] [Full Text] [Related]

  • 34. The role of L3T4+ cells in the pathogenesis of lupus in lpr-bearing mice. I. Defects in the production of interleukins 2 and 3.
    Santoro TJ, Lehmann KR, Batt RA, Kotzin BL.
    Eur J Immunol; 1987 Aug 15; 17(8):1131-6. PubMed ID: 3113978
    [Abstract] [Full Text] [Related]

  • 35. Expression of a bone marrow-associated Ly-6 determinant on the T cell population expanding in the lymph nodes of the autoimmune mouse strain MRL/Mp-lpr/lpr.
    Melino MR, Dumont FJ, Habbersett RC, Hansen TH.
    J Immunol; 1983 Apr 15; 130(4):1843-7. PubMed ID: 6601141
    [Abstract] [Full Text] [Related]

  • 36. The in vivo behavior of T cell clones: altered migration due to loss of the lymphocyte surface homing receptor.
    Dailey MO, Gallatin WM, Weissman IL.
    J Mol Cell Immunol; 1985 Apr 15; 2(1):27-36. PubMed ID: 2978224
    [Abstract] [Full Text] [Related]

  • 37. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice.
    Davignon JL, Cohen PL, Eisenberg RA.
    J Immunol; 1988 Sep 15; 141(6):1848-54. PubMed ID: 3262641
    [Abstract] [Full Text] [Related]

  • 38. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice.
    Takei F.
    J Immunol; 1984 Oct 15; 133(4):1951-4. PubMed ID: 6332141
    [Abstract] [Full Text] [Related]

  • 39. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects.
    Waterfield JD, Fairhurst M, Chu R, Levy JG.
    Immunology; 1987 Jun 15; 61(2):173-8. PubMed ID: 2954899
    [Abstract] [Full Text] [Related]

  • 40. T cells from autoimmune "IL 2-defective" MRL-lpr/lpr mice continue to grow in vitro and produce IL 2 constitutively.
    Rosenberg YJ, Steinberg AD, Santoro TJ.
    J Immunol; 1984 Nov 15; 133(5):2545-8. PubMed ID: 6434632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.